DailyDoctor Archive Specialties Get app
Back to the 28 October 2026 edition

Research · 02 of 04

Vogt-Koyanagi-Harada disease presenting as angle closure

Look for choroidal thickening or effusion in bilateral or inflamed angle closure, and consider VKH before treating it as primary.

Design
Single-centre retrospective case series
Population
18 patients (36 eyes) among 768 with VKH who presented with angle closure
Primary outcome
Presentation, diagnostic delay and final visual acuity
Effect
Diagnostic delay 1 month to 7 years; presenting BCVA independently predicted final BCVA (p = 0.039)

This retrospective study from an Indian tertiary eye hospital reviewed 768 patients with Vogt-Koyanagi-Harada disease seen between 2013 and 2020. Eighteen patients, 36 eyes or 3.9%, first presented with angle closure: half primary angle closure and half secondary angle closure glaucoma. Mean age was 44, and 89% were women.

The fundus was often not examined at first because of media opacity, and the diagnosis of VKH was delayed by between one month and seven years. Imaging, where done, showed choroidal thickening and ciliochoroidal effusion. With treatment, mean pressure fell from 26.3 to 14 mmHg. Poor presenting vision and delay of more than a month were associated with worse final vision on univariate analysis; presenting vision remained the independent predictor.

The lesson is a familiar one for any secondary angle closure: bilateral shallowing, especially with inflammation or in a younger patient, should prompt a look behind the lens. Ultrasound biomicroscopy, B-scan and OCT can show choroidal thickening or effusion even when the media are hazy, and recognising VKH changes treatment from laser and surgery to immunosuppression.

  • Consider secondary causes when angle closure is bilateral, especially with inflammation.
  • Use B-scan, ultrasound biomicroscopy or OCT to look for choroidal thickening when the fundus is hidden.
  • Ask about headache, tinnitus, hearing change and skin or hair changes that suggest VKH.
  • Refer promptly to uveitis services when VKH is suspected, since delay was linked to worse vision.
  • Do not rely on peripheral iridotomy alone until the cause of angle closure is clear.

Why it matters

Treating VKH as primary angle closure delays the immunosuppression that protects vision.

The statistics, in plain English

The association between delay and worse vision came from univariate analysis and did not hold on multivariate analysis, so it may partly reflect that patients diagnosed late also presented with worse vision. The series is small, 18 patients, and descriptive.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

corneaglaucomaretina

Tomorrow morning, before your first patient

One edition a day for ophthalmology, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free
Daily Doctor All 27 specialties, every morning. Free.
Get the app